IMVT vs BETA Comparison

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

BETA Technologies Inc is an aerospace company. The group has developed an electric aircraft platform and propulsion systems that are positioned to transform the aviation industry forward into a new phase of growth. It designs, manufactures, and sells high-performance electric aircraft, modern electric propulsion systems, charging systems, and components. The group also invested in the underlying infrastructure of this breakthrough technology, which is critical to bringing electric aviation to life. The group has developed a differentiated presence in North America and is well-positioned to expand globally. Its products and services are Aircraft, Charge, Motor, Battery, Flight Controls, and Training. It has one operating segment: Development and Manufacturing of Electric Aircraft.